| # | Drug | Count |
|---|---|---|
| 0 | IPILIMUMAB | 4 |
| 1 | NAFCILLIN | 3 |
| 2 | NAFCILLIN SODIUM | 3 |
| 3 | ALLOPURINOL | 2 |
| 4 | CYCLOPHOSPHAMIDE | 2 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 7 | PREDNISOLONE | 2 |
| 8 | PREDNISOLONE ORAL | 2 |
| 9 | PREDNISOLONE ORAL SOLUTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 1 | STREPTOMYCIN | 1 | 0.0009 |
| 2 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| 3 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | 1 | 0.0002 |
| 4 | CEFOTAXIME INJECTION | 1 | 0.0002 |
| 5 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 6 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 7 | DACARBAZINE | 1 | 0.0001 |
| 8 | METHIMAZOLE | 1 | 0.0001 |
| 9 | PYRAZINAMIDE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 4 |
| 1 | Alkylating Drug [EPC] | 3 |
| 2 | Corticosteroid [EPC] | 3 |
| 3 | Aminosalicylate [EPC] | 2 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 2 |
| 6 | Aldosterone Antagonist [EPC] | 1 |
| 7 | Antimycobacterial [EPC] | 1 |
| 8 | Benzodiazepine [EPC] | 1 |
| 9 | Cardiac Glycoside [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 2 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 7 | Methylxanthine [EPC] | 1 | 0.0000 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |